Joseph Saseen, PharmD, discusses how pharmacists can overcome therapeutic inertia and sequence non-statin therapies to help patients reach individualized LDL-C goals.

Advances in Alzheimer disease diagnosis and treatment are reshaping care, highlighting the pharmacist’s role in medication management, patient education, and overcoming barriers to access.

Cisgender Black and Brown women remain significantly underserved by PrEP due to provider knowledge gaps and medical mistrust.

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers have not directly compared their bleeding risk until last year.

A simple formula reveals why time—not income—is the most powerful wealth-building tool available to pharmacists.

Gonzelez describes advances in Alzheimer disease diagnostics and disease-modifying therapies and highlights the critical role pharmacists play in medication management, caregiver education, and improving treatment access.